GREENWICH LIFESCIENCES, INC. Earnings Per Share, Basic and Diluted
GREENWICH LIFESCIENCES, INC. (GLSI) reported Earnings Per Share, Basic and Diluted of -$0.35 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-21.
Discontinued › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-21
- GREENWICH LIFESCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.07.
- GREENWICH LIFESCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.06.
- GREENWICH LIFESCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.05.
- GREENWICH LIFESCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.03.
- GREENWICH LIFESCIENCES, INC. earnings per share, basic and diluted for fiscal 2021 was -$0.35.
- GREENWICH LIFESCIENCES, INC. earnings per share, basic and diluted for fiscal 2020 was -$0.20.
- GREENWICH LIFESCIENCES, INC. earnings per share, basic and diluted for fiscal 2019 was -$1.52.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$0.35 10-K · filed 2022-03-21 | |||
| 2021-09-30 | -$0.07 10-Q · filed 2021-11-15 | -$0.12 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.17 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$0.06 10-Q · filed 2021-08-13 | -$0.11 10-Q · filed 2021-08-13 | ||
| 2021-03-31 | -$0.05 10-Q · filed 2021-05-20 | |||
| 2020-12-31 | -$0.20 10-K · filed 2022-03-21 | |||
| 2020-09-30 | -$0.03 10-Q · filed 2021-11-15 | -$0.05 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$0.08 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$0.02 10-Q · filed 2021-08-13 | -$0.05 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$0.03 10-Q · filed 2021-05-20 | |||
| 2019-12-31 | -$1.52 10-K · filed 2021-03-31 | |||
| 2019-09-30 | -$1.15 10-Q · filed 2020-11-16 | -$13.26 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |